SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-138190
Filing Date
2021-11-12
Accepted
2021-11-12 17:01:15
Documents
50
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snpx-20210930x10q.htm   iXBRL 10-Q 1490772
2 EXHIBIT 31.1 snpx-20210930xex31d1.htm EX-31.1 10927
3 EXHIBIT 31.2 snpx-20210930xex31d2.htm EX-31.2 10872
4 EXHIBIT 32.1 snpx-20210930xex32d1.htm EX-32.1 6173
5 EXHIBIT 32.2 snpx-20210930xex32d2.htm EX-32.2 5817
  Complete submission text file 0001104659-21-138190.txt   5296324

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA snpx-20210930.xsd EX-101.SCH 51818
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snpx-20210930_cal.xml EX-101.CAL 28445
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snpx-20210930_def.xml EX-101.DEF 181264
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20210930_lab.xml EX-101.LAB 332973
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20210930_pre.xml EX-101.PRE 284157
11 EXTRACTED XBRL INSTANCE DOCUMENT snpx-20210930x10q_htm.xml XML 685119
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40458 | Film No.: 211404625
SIC: 2834 Pharmaceutical Preparations